PerkinElmer Inc (PKI.N)
96.61USD
21 Sep 2018
$0.03 (+0.03%)
$96.58
$96.75
$97.48
$96.52
464,642
157,536
$97.48
$67.51
About
Overall
| Beta: | 1.01 |
| Market Cap(Mil.): | $10,698.01 |
| Shares Outstanding(Mil.): | 110.73 |
| Dividend: | 0.07 |
| Yield (%): | 0.29 |
Financials
| PKI.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 41.96 | 47.86 | 32.69 |
| EPS (TTM): | 2.30 | -- | -- |
| ROI: | 5.51 | 8.48 | 12.72 |
| ROE: | 10.30 | 12.20 | 14.85 |
UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street
April 30 Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.
PerkinElmer first-quarter profit beats Street view
April 30 Laboratory equipment maker PerkinElmer on Monday reported slightly higher-than-expected first-quarter profit and revenue and raised its full-year earnings forecast as sales grew in both of its business units.
BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer
* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:
BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics
* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS
BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering
* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING Source text: (https://bit.ly/2q3PNq6) Further company coverage:
Competitors
| Price | Chg | |
|---|---|---|
| Thermo Fisher Scientific Inc. (TMO.N) | $243.49 | +0.99 |
| Agilent Technologies Inc (A.N) | $70.72 | -0.41 |
| Waters Corporation (WAT.N) | $196.76 | -0.53 |
Estimates